TuHURA Biosciences Files 8-K/A Amendment

Ticker: HURA · Form: 8-K/A · Filed: May 7, 2025 · CIK: 1498382

Sentiment: neutral

Topics: corporate-governance, amendment, personnel-changes

TL;DR

TuHURA Biosciences amended its 8-K filing, updating info on director/officer changes and compensation.

AI Summary

TuHURA Biosciences, Inc./NV filed an amendment (8-K/A) on May 7, 2025, to a report originally dated March 7, 2025. The amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. The company, formerly known as Kintara Therapeutics, Inc., is incorporated in Nevada and based in Tampa, Florida.

Why It Matters

This amendment provides updated information regarding changes in the company's board of directors and executive officers, which can impact corporate governance and strategic direction.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous report and primarily concerns corporate governance and personnel changes, not immediate financial distress or major operational shifts.

Key Players & Entities

FAQ

What specific items are being amended in this 8-K/A filing?

This 8-K/A amends items related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

When was the original report filed, and when is this amendment filed?

The original report was dated March 7, 2025, and this amendment (8-K/A) was filed as of May 7, 2025.

What was TuHURA Biosciences, Inc./NV formerly known as?

TuHURA Biosciences, Inc./NV was formerly known as Kintara Therapeutics, Inc.

In which state is TuHURA Biosciences, Inc./NV incorporated?

TuHURA Biosciences, Inc./NV is incorporated in Nevada.

What is the business address of TuHURA Biosciences, Inc./NV?

The business address is 10500 University Center Dr., Suite 110, Tampa, Florida 33612.

Filing Details

This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 7, 2025 regarding TuHURA Biosciences, Inc./NV (HURA).

View full filing on EDGAR

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing